Rank | Gene Set | Z-score |
---|---|---|
1 | lymph vessel development (GO:0001945) | 7.37310412 |
2 | vascular endothelial growth factor signaling pathway (GO:0038084) | 6.59650764 |
3 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.71341385 |
4 | endothelium development (GO:0003158) | 5.13198919 |
5 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 5.10740068 |
6 | low-density lipoprotein particle clearance (GO:0034383) | 4.89806966 |
7 | transcytosis (GO:0045056) | 4.87651052 |
8 | regulation of sequestering of triglyceride (GO:0010889) | 4.83270509 |
9 | NADH metabolic process (GO:0006734) | 4.72846525 |
10 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 4.47166030 |
11 | lymphangiogenesis (GO:0001946) | 4.45389871 |
12 | protein heterotrimerization (GO:0070208) | 4.18778517 |
13 | urea cycle (GO:0000050) | 4.01915351 |
14 | ethanol oxidation (GO:0006069) | 3.97618707 |
15 | heart trabecula formation (GO:0060347) | 3.93473433 |
16 | urea metabolic process (GO:0019627) | 3.89461854 |
17 | barbed-end actin filament capping (GO:0051016) | 3.83363808 |
18 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.74253315 |
19 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71333089 |
20 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71333089 |
21 | positive regulation of fatty acid oxidation (GO:0046321) | 3.70947174 |
22 | atrioventricular valve morphogenesis (GO:0003181) | 3.70912046 |
23 | glomerular filtration (GO:0003094) | 3.65727703 |
24 | cGMP-mediated signaling (GO:0019934) | 3.63559387 |
25 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.61803483 |
26 | nitrogen cycle metabolic process (GO:0071941) | 3.61126029 |
27 | endothelial cell morphogenesis (GO:0001886) | 3.56056523 |
28 | white fat cell differentiation (GO:0050872) | 3.55820643 |
29 | brown fat cell differentiation (GO:0050873) | 3.55388540 |
30 | cell migration involved in heart development (GO:0060973) | 3.53230952 |
31 | intestinal absorption (GO:0050892) | 3.48759222 |
32 | cell adhesion mediated by integrin (GO:0033627) | 3.47772579 |
33 | desmosome organization (GO:0002934) | 3.46482897 |
34 | renal filtration (GO:0097205) | 3.43259848 |
35 | diacylglycerol metabolic process (GO:0046339) | 3.40862535 |
36 | cellular response to vitamin (GO:0071295) | 3.37452464 |
37 | morphogenesis of an endothelium (GO:0003159) | 3.30801291 |
38 | endothelial tube morphogenesis (GO:0061154) | 3.30801291 |
39 | substrate-dependent cell migration (GO:0006929) | 3.29722475 |
40 | ethanol metabolic process (GO:0006067) | 3.29322602 |
41 | basement membrane organization (GO:0071711) | 3.27460609 |
42 | sprouting angiogenesis (GO:0002040) | 3.25481354 |
43 | phagocytosis, recognition (GO:0006910) | 3.24904821 |
44 | Notch signaling involved in heart development (GO:0061314) | 3.24135610 |
45 | endothelial cell differentiation (GO:0045446) | 3.23202353 |
46 | regulation of endothelial cell differentiation (GO:0045601) | 3.22524912 |
47 | regulation of cholesterol storage (GO:0010885) | 3.21966571 |
48 | fatty acid transmembrane transport (GO:1902001) | 3.20911070 |
49 | lipid particle organization (GO:0034389) | 3.18053005 |
50 | cellular glucuronidation (GO:0052695) | 3.17294468 |
51 | smooth muscle tissue development (GO:0048745) | 3.16183576 |
52 | blood vessel endothelial cell migration (GO:0043534) | 3.14478220 |
53 | regulation of plasminogen activation (GO:0010755) | 3.13555041 |
54 | blood vessel maturation (GO:0001955) | 3.12895120 |
55 | regulation of vasculogenesis (GO:2001212) | 3.09475831 |
56 | renal system process involved in regulation of blood volume (GO:0001977) | 3.08758586 |
57 | polyketide metabolic process (GO:0030638) | 3.07725587 |
58 | doxorubicin metabolic process (GO:0044598) | 3.07725587 |
59 | daunorubicin metabolic process (GO:0044597) | 3.07725587 |
60 | surfactant homeostasis (GO:0043129) | 3.06712028 |
61 | protein retention in ER lumen (GO:0006621) | 3.06088649 |
62 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.05764744 |
63 | ovulation from ovarian follicle (GO:0001542) | 3.04344684 |
64 | glycerolipid catabolic process (GO:0046503) | 3.02747976 |
65 | patterning of blood vessels (GO:0001569) | 3.02253804 |
66 | primary alcohol catabolic process (GO:0034310) | 2.98176578 |
67 | positive regulation of lipid catabolic process (GO:0050996) | 2.97542399 |
68 | positive regulation of receptor recycling (GO:0001921) | 2.95097373 |
69 | triglyceride catabolic process (GO:0019433) | 2.94736716 |
70 | uronic acid metabolic process (GO:0006063) | 2.93628942 |
71 | glucuronate metabolic process (GO:0019585) | 2.93628942 |
72 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.93484381 |
73 | regulation of fatty acid oxidation (GO:0046320) | 2.92439736 |
74 | induction of positive chemotaxis (GO:0050930) | 2.92173567 |
75 | glomerular basement membrane development (GO:0032836) | 2.91976568 |
76 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.89423521 |
77 | primary alcohol metabolic process (GO:0034308) | 2.88653395 |
78 | positive regulation of pseudopodium assembly (GO:0031274) | 2.88587935 |
79 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.87802512 |
80 | potassium ion import (GO:0010107) | 2.87037205 |
81 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.86949297 |
82 | hemidesmosome assembly (GO:0031581) | 2.85702123 |
83 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.83569347 |
84 | trabecula formation (GO:0060343) | 2.83101784 |
85 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.82905270 |
86 | endocardial cushion morphogenesis (GO:0003203) | 2.82624978 |
87 | glomerular visceral epithelial cell development (GO:0072015) | 2.81781165 |
88 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.81531635 |
89 | positive regulation of vasculogenesis (GO:2001214) | 2.81328251 |
90 | endothelial cell proliferation (GO:0001935) | 2.81161201 |
91 | extracellular fibril organization (GO:0043206) | 2.80117153 |
92 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.78421331 |
93 | glomerulus development (GO:0032835) | 2.76951333 |
94 | endothelial cell chemotaxis (GO:0035767) | 2.76643959 |
95 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.75648381 |
96 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.75510355 |
97 | L-phenylalanine metabolic process (GO:0006558) | 2.75510355 |
98 | carnitine shuttle (GO:0006853) | 2.75400691 |
99 | cellular response to nutrient (GO:0031670) | 2.73132781 |
100 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.73047390 |
101 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.72983242 |
102 | mesenchymal cell development (GO:0014031) | 2.72708067 |
103 | oxaloacetate metabolic process (GO:0006107) | 2.72595841 |
104 | cardiac myofibril assembly (GO:0055003) | 2.72463287 |
105 | regulation of metalloenzyme activity (GO:0048552) | 2.70713394 |
106 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.68954712 |
107 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.68715697 |
108 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.66950038 |
109 | negative regulation of catenin import into nucleus (GO:0035414) | 2.66361735 |
110 | stress fiber assembly (GO:0043149) | 2.66004100 |
111 | blood vessel remodeling (GO:0001974) | 2.65954970 |
112 | actin filament depolymerization (GO:0030042) | 2.64488782 |
113 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.64476752 |
114 | sulfur amino acid catabolic process (GO:0000098) | 2.64025090 |
115 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.63940425 |
116 | fibril organization (GO:0097435) | 2.63739478 |
117 | heart valve morphogenesis (GO:0003179) | 2.63568573 |
118 | cardiac muscle cell proliferation (GO:0060038) | 2.63560273 |
119 | positive regulation of endothelial cell migration (GO:0010595) | 2.63299106 |
120 | positive regulation of extracellular matrix organization (GO:1903055) | 2.62827692 |
121 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.62580261 |
122 | protein carboxylation (GO:0018214) | 2.62580261 |
123 | regulation of lipoprotein metabolic process (GO:0050746) | 2.62372093 |
124 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.62170252 |
125 | positive regulation of macrophage cytokine production (GO:0060907) | 2.61184948 |
126 | regulation of pseudopodium assembly (GO:0031272) | 2.60598407 |
127 | cell-substrate junction assembly (GO:0007044) | 2.59826585 |
128 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.59786523 |
129 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.59528742 |
130 | plasma membrane repair (GO:0001778) | 2.59174684 |
131 | bile acid and bile salt transport (GO:0015721) | 2.58236063 |
132 | vasculogenesis (GO:0001570) | 2.57311728 |
133 | embryonic heart tube development (GO:0035050) | 2.56705214 |
134 | GDP-mannose metabolic process (GO:0019673) | 2.56280391 |
135 | neutral lipid catabolic process (GO:0046461) | 2.55649493 |
136 | acylglycerol catabolic process (GO:0046464) | 2.55649493 |
137 | L-serine transport (GO:0015825) | 2.53970536 |
138 | aorta morphogenesis (GO:0035909) | 2.53459244 |
139 | negative regulation of endothelial cell migration (GO:0010596) | 2.53347750 |
140 | regulation of positive chemotaxis (GO:0050926) | 2.52851383 |
141 | regulation of macrophage cytokine production (GO:0010935) | 2.52251838 |
142 | triglyceride metabolic process (GO:0006641) | 2.52211040 |
143 | arginine metabolic process (GO:0006525) | 2.51651003 |
144 | chemical homeostasis within a tissue (GO:0048875) | 2.51605954 |
145 | adhesion of symbiont to host (GO:0044406) | 2.51239339 |
146 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.50222301 |
147 | arginine catabolic process (GO:0006527) | 2.50049627 |
148 | sarcomere organization (GO:0045214) | 2.49217192 |
149 | protein localization to cell surface (GO:0034394) | 2.49118327 |
150 | endodermal cell differentiation (GO:0035987) | 2.48657413 |
151 | ventricular septum morphogenesis (GO:0060412) | 2.48637274 |
152 | adhesion of symbiont to host cell (GO:0044650) | 2.47610054 |
153 | virion attachment to host cell (GO:0019062) | 2.47610054 |
154 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.47502394 |
155 | regulation of tight junction assembly (GO:2000810) | 2.47340350 |
156 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.46329652 |
157 | cell proliferation involved in kidney development (GO:0072111) | 2.46247096 |
158 | collagen fibril organization (GO:0030199) | 2.45898183 |
159 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.45842699 |
160 | protein targeting to plasma membrane (GO:0072661) | 2.45814846 |
161 | blood vessel morphogenesis (GO:0048514) | 2.45426488 |
162 | fatty acid beta-oxidation (GO:0006635) | 2.45057441 |
163 | regulation of endothelial cell migration (GO:0010594) | 2.44937114 |
164 | apoptotic cell clearance (GO:0043277) | 2.43979802 |
165 | regulation of triglyceride catabolic process (GO:0010896) | 2.43703404 |
166 | negative regulation of cartilage development (GO:0061037) | 2.43673178 |
167 | negative regulation of fatty acid transport (GO:2000192) | 2.43285210 |
168 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.42295445 |
169 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.41236386 |
170 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.40735514 |
171 | acylglycerol homeostasis (GO:0055090) | 2.40216536 |
172 | triglyceride homeostasis (GO:0070328) | 2.40216536 |
173 | fatty acid catabolic process (GO:0009062) | 2.38937491 |
174 | glycerol metabolic process (GO:0006071) | 2.38401338 |
175 | chondrocyte proliferation (GO:0035988) | 2.36827113 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.83659549 |
2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.69805799 |
3 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.02645771 |
4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.65047143 |
5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.63900476 |
6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.05299270 |
7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.00652750 |
8 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.60431816 |
9 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.47005775 |
10 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.40176745 |
11 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.35467300 |
12 | CJUN_26792858_Chip-Seq_BT549_Human | 2.17377669 |
13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.17135111 |
14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.13261736 |
15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.11686347 |
16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.10489854 |
17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.07832466 |
18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.00432776 |
19 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.98282908 |
20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.92361625 |
21 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.85557862 |
22 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.82944686 |
23 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.82944686 |
24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.82156545 |
25 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.72759539 |
26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.72662079 |
27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.72364707 |
28 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.69662073 |
29 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.68983351 |
30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68158930 |
31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67718860 |
32 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.63810316 |
33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.63793815 |
34 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.59612450 |
35 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.59612450 |
36 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.58494096 |
37 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58414551 |
38 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.56888780 |
39 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.54732702 |
40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52693354 |
41 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.50656133 |
42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.50656133 |
43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.50408395 |
44 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.50029329 |
45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47975435 |
46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47723069 |
47 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.46295835 |
48 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.44895846 |
49 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.44428627 |
50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.44121214 |
51 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.44021716 |
52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41384436 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41254822 |
54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38704818 |
55 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36917931 |
56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.36787805 |
57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36619742 |
58 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.36483780 |
59 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35601668 |
60 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33421602 |
61 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32483046 |
62 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31127619 |
63 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.29767331 |
64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28652602 |
65 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.28613266 |
66 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27626523 |
67 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.26024277 |
68 | ATF3_27146783_Chip-Seq_COLON_Human | 1.25295994 |
69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24719110 |
70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22635749 |
71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22388296 |
72 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.20150391 |
73 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.20082004 |
74 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19664235 |
75 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.19411179 |
76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19105243 |
77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18728257 |
78 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18492948 |
79 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.16754506 |
80 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.16118274 |
81 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14355895 |
82 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.13508316 |
83 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13402255 |
84 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13227858 |
85 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.12878746 |
86 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10775035 |
87 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10775035 |
88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10739387 |
89 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.10456324 |
90 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.09766395 |
91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09735535 |
92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09607201 |
93 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.09391271 |
94 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.09239666 |
95 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.08849913 |
96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07740933 |
97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06717055 |
98 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.05930417 |
99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02448069 |
100 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.01883811 |
101 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.00951516 |
102 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00602891 |
103 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00282317 |
104 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99932192 |
105 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99924282 |
106 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99249325 |
107 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98814093 |
108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98453207 |
109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98286810 |
110 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.98230760 |
111 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97714099 |
112 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.97537050 |
113 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.97306920 |
114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96312453 |
115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95829500 |
116 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.95810049 |
117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95319730 |
118 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94540896 |
119 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92917822 |
120 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92213370 |
121 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.91363292 |
122 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.91169857 |
123 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.90820309 |
124 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.90820309 |
125 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.90820309 |
126 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.90159667 |
127 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89663117 |
128 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.88522562 |
129 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88215703 |
130 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88003486 |
131 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.87186566 |
132 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.87034822 |
133 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86660585 |
134 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.85096625 |
135 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.83947445 |
136 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83628164 |
137 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83094385 |
138 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82811824 |
139 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82018213 |
140 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.81554608 |
141 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.80438591 |
142 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.79822131 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001879_abnormal_lymphatic_vessel | 4.62279150 |
2 | MP0005670_abnormal_white_adipose | 4.52542824 |
3 | MP0010368_abnormal_lymphatic_system | 4.48727468 |
4 | MP0008438_abnormal_cutaneous_collagen | 4.35642184 |
5 | MP0004272_abnormal_basement_membrane | 4.05938876 |
6 | MP0003724_increased_susceptibility_to | 3.50545665 |
7 | MP0000013_abnormal_adipose_tissue | 3.37064697 |
8 | MP0002139_abnormal_hepatobiliary_system | 3.25461559 |
9 | MP0005360_urolithiasis | 3.13810007 |
10 | MP0003279_aneurysm | 2.75055706 |
11 | MP0002837_dystrophic_cardiac_calcinosis | 2.71527819 |
12 | MP0005666_abnormal_adipose_tissue | 2.67007618 |
13 | MP0004130_abnormal_muscle_cell | 2.63456968 |
14 | MP0005275_abnormal_skin_tensile | 2.52968086 |
15 | MP0003868_abnormal_feces_composition | 2.41924809 |
16 | MP0006054_spinal_hemorrhage | 2.41500709 |
17 | MP0004185_abnormal_adipocyte_glucose | 2.37926098 |
18 | MP0004084_abnormal_cardiac_muscle | 2.37866196 |
19 | MP0004215_abnormal_myocardial_fiber | 2.37788311 |
20 | MP0005375_adipose_tissue_phenotype | 2.22581094 |
21 | MP0005167_abnormal_blood-brain_barrier | 2.19111485 |
22 | MP0005365_abnormal_bile_salt | 2.16060235 |
23 | MP0003828_pulmonary_edema | 2.07668404 |
24 | MP0000751_myopathy | 2.05431571 |
25 | MP0000003_abnormal_adipose_tissue | 2.00945728 |
26 | MP0009384_cardiac_valve_regurgitation | 1.95587172 |
27 | MP0010234_abnormal_vibrissa_follicle | 1.95414461 |
28 | MP0005503_abnormal_tendon_morphology | 1.94764354 |
29 | MP0001958_emphysema | 1.94370582 |
30 | MP0006138_congestive_heart_failure | 1.91467879 |
31 | MP0002295_abnormal_pulmonary_circulatio | 1.88869847 |
32 | MP0003705_abnormal_hypodermis_morpholog | 1.81856405 |
33 | MP0009780_abnormal_chondrocyte_physiolo | 1.79745415 |
34 | MP0005623_abnormal_meninges_morphology | 1.79465587 |
35 | MP0005085_abnormal_gallbladder_physiolo | 1.78379188 |
36 | MP0001661_extended_life_span | 1.71098203 |
37 | MP0008775_abnormal_heart_ventricle | 1.69976043 |
38 | MP0004484_altered_response_of | 1.69319228 |
39 | MP0000749_muscle_degeneration | 1.66983806 |
40 | MP0005330_cardiomyopathy | 1.66531008 |
41 | MP0000750_abnormal_muscle_regeneration | 1.64166050 |
42 | MP0004147_increased_porphyrin_level | 1.63272628 |
43 | MP0005620_abnormal_muscle_contractility | 1.62822119 |
44 | MP0000767_abnormal_smooth_muscle | 1.62677309 |
45 | MP0004036_abnormal_muscle_relaxation | 1.62562415 |
46 | MP0005164_abnormal_response_to | 1.58504042 |
47 | MP0003191_abnormal_cellular_cholesterol | 1.56799697 |
48 | MP0005595_abnormal_vascular_smooth | 1.56026276 |
49 | MP0003950_abnormal_plasma_membrane | 1.54866234 |
50 | MP0002972_abnormal_cardiac_muscle | 1.54548486 |
51 | MP0005165_increased_susceptibility_to | 1.50192973 |
52 | MP0005385_cardiovascular_system_phenoty | 1.48088275 |
53 | MP0001544_abnormal_cardiovascular_syste | 1.48088275 |
54 | MP0003959_abnormal_lean_body | 1.42656751 |
55 | MP0003566_abnormal_cell_adhesion | 1.39975584 |
56 | MP0000343_altered_response_to | 1.37644719 |
57 | MP0002009_preneoplasia | 1.37043300 |
58 | MP0005257_abnormal_intraocular_pressure | 1.36943585 |
59 | MP0010030_abnormal_orbit_morphology | 1.31862301 |
60 | MP0002108_abnormal_muscle_morphology | 1.29960261 |
61 | MP0000249_abnormal_blood_vessel | 1.29717874 |
62 | MP0002970_abnormal_white_adipose | 1.26228511 |
63 | MP0004087_abnormal_muscle_fiber | 1.26147996 |
64 | MP0005409_darkened_coat_color | 1.24475445 |
65 | MP0004883_abnormal_blood_vessel | 1.22319483 |
66 | MP0010630_abnormal_cardiac_muscle | 1.22085684 |
67 | MP0001849_ear_inflammation | 1.20270385 |
68 | MP0010352_gastrointestinal_tract_polyps | 1.17449025 |
69 | MP0002796_impaired_skin_barrier | 1.15448175 |
70 | MP0002128_abnormal_blood_circulation | 1.14711784 |
71 | MP0000230_abnormal_systemic_arterial | 1.13059754 |
72 | MP0005084_abnormal_gallbladder_morpholo | 1.12121682 |
73 | MP0002127_abnormal_cardiovascular_syste | 1.10246743 |
74 | MP0009379_abnormal_foot_pigmentation | 1.08669859 |
75 | MP0002166_altered_tumor_susceptibility | 1.08627414 |
76 | MP0003091_abnormal_cell_migration | 1.05382345 |
77 | MP0004085_abnormal_heartbeat | 1.04964133 |
78 | MP0002896_abnormal_bone_mineralization | 1.03755553 |
79 | MP0002332_abnormal_exercise_endurance | 1.02409454 |
80 | MP0001614_abnormal_blood_vessel | 1.02366349 |
81 | MP0000762_abnormal_tongue_morphology | 1.00996380 |
82 | MP0009115_abnormal_fat_cell | 1.00853634 |
83 | MP0004019_abnormal_vitamin_homeostasis | 1.00173676 |
84 | MP0000467_abnormal_esophagus_morphology | 0.98491666 |
85 | MP0001542_abnormal_bone_strength | 0.97238031 |
86 | MP0009840_abnormal_foam_cell | 0.97206063 |
87 | MP0009643_abnormal_urine_homeostasis | 0.95899794 |
88 | MP0002971_abnormal_brown_adipose | 0.95426462 |
89 | MP0010329_abnormal_lipoprotein_level | 0.95228378 |
90 | MP0005501_abnormal_skin_physiology | 0.92440442 |
91 | MP0000858_altered_metastatic_potential | 0.91544355 |
92 | MP0002138_abnormal_hepatobiliary_system | 0.90363886 |
93 | MP0001666_abnormal_nutrient_absorption | 0.90211034 |
94 | MP0002925_abnormal_cardiovascular_devel | 0.89691254 |
95 | MP0003879_abnormal_hair_cell | 0.89615631 |
96 | MP0005332_abnormal_amino_acid | 0.89391328 |
97 | MP0003806_abnormal_nucleotide_metabolis | 0.88905050 |
98 | MP0003045_fibrosis | 0.87238279 |
99 | MP0005388_respiratory_system_phenotype | 0.85722601 |
100 | MP0002133_abnormal_respiratory_system | 0.85722601 |
101 | MP0005508_abnormal_skeleton_morphology | 0.83649127 |
102 | MP0002877_abnormal_melanocyte_morpholog | 0.83401778 |
103 | MP0000759_abnormal_skeletal_muscle | 0.83044923 |
104 | MP0000163_abnormal_cartilage_morphology | 0.82577541 |
105 | MP0003646_muscle_fatigue | 0.81980920 |
106 | MP0005451_abnormal_body_composition | 0.81393929 |
107 | MP0003137_abnormal_impulse_conducting | 0.81212273 |
108 | MP0003453_abnormal_keratinocyte_physiol | 0.81204504 |
109 | MP0004858_abnormal_nervous_system | 0.80172508 |
110 | MP0000609_abnormal_liver_physiology | 0.80165201 |
111 | MP0005369_muscle_phenotype | 0.79975304 |
112 | MP0002060_abnormal_skin_morphology | 0.79356698 |
113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79032403 |
114 | MP0005058_abnormal_lysosome_morphology | 0.78683044 |
115 | MP0009053_abnormal_anal_canal | 0.76838363 |
116 | MP0001243_abnormal_dermal_layer | 0.76549765 |
117 | MP0005535_abnormal_body_temperature | 0.76376518 |
118 | MP0001764_abnormal_homeostasis | 0.75519107 |
119 | MP0002933_joint_inflammation | 0.75307550 |
120 | MP0001664_abnormal_digestion | 0.73326118 |
121 | MP0000733_abnormal_muscle_development | 0.73039587 |
122 | MP0003300_gastrointestinal_ulcer | 0.72391205 |
123 | MP0001881_abnormal_mammary_gland | 0.70825431 |
124 | MP0009278_abnormal_bone_marrow | 0.69579093 |
125 | MP0000678_abnormal_parathyroid_gland | 0.68870357 |
126 | MP0000266_abnormal_heart_morphology | 0.68619673 |
127 | MP0003011_delayed_dark_adaptation | 0.68241507 |
128 | MP0001663_abnormal_digestive_system | 0.67742368 |
129 | MP0001533_abnormal_skeleton_physiology | 0.67620565 |
130 | MP0005023_abnormal_wound_healing | 0.66422697 |
131 | MP0002106_abnormal_muscle_physiology | 0.66330424 |
132 | MP0003690_abnormal_glial_cell | 0.65153955 |
133 | MP0001851_eye_inflammation | 0.64648557 |
134 | MP0008004_abnormal_stomach_pH | 0.61422810 |
135 | MP0005334_abnormal_fat_pad | 0.61411515 |
136 | MP0005083_abnormal_biliary_tract | 0.60574497 |
137 | MP0003186_abnormal_redox_activity | 0.58785697 |
138 | MP0000747_muscle_weakness | 0.58333150 |
139 | MP0003385_abnormal_body_wall | 0.57677386 |
140 | MP0002118_abnormal_lipid_homeostasis | 0.57084570 |
141 | MP0002006_tumorigenesis | 0.56777494 |
142 | MP0003448_altered_tumor_morphology | 0.56579360 |
143 | MP0002269_muscular_atrophy | 0.52216514 |
144 | MP0008961_abnormal_basal_metabolism | 0.51978300 |
145 | MP0002876_abnormal_thyroid_physiology | 0.51815527 |
146 | MP0001784_abnormal_fluid_regulation | 0.51673929 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Premature rupture of membranes (HP:0001788) | 4.83457732 |
2 | Aortic aneurysm (HP:0004942) | 4.66044276 |
3 | Protrusio acetabuli (HP:0003179) | 4.52429703 |
4 | Broad metatarsal (HP:0001783) | 4.43305460 |
5 | Muscle fiber splitting (HP:0003555) | 4.32129739 |
6 | Increased connective tissue (HP:0009025) | 4.18176685 |
7 | Short hallux (HP:0010109) | 4.09956883 |
8 | Nonimmune hydrops fetalis (HP:0001790) | 4.02227634 |
9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.97832531 |
10 | Aortic dissection (HP:0002647) | 3.93068864 |
11 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.79722181 |
12 | Spinal rigidity (HP:0003306) | 3.72989125 |
13 | Cerebral aneurysm (HP:0004944) | 3.70798429 |
14 | Acanthosis nigricans (HP:0000956) | 3.55539302 |
15 | Polycythemia (HP:0001901) | 3.49186989 |
16 | Vertebral compression fractures (HP:0002953) | 3.48161918 |
17 | Ventricular tachycardia (HP:0004756) | 3.45929858 |
18 | Pulmonary artery stenosis (HP:0004415) | 3.43680090 |
19 | Right ventricular cardiomyopathy (HP:0011663) | 3.43119491 |
20 | Difficulty running (HP:0009046) | 3.42589125 |
21 | Vascular tortuosity (HP:0004948) | 3.36881743 |
22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.33322133 |
23 | Congenital, generalized hypertrichosis (HP:0004540) | 3.31089424 |
24 | Hyporeflexia of lower limbs (HP:0002600) | 3.27227537 |
25 | Lipoatrophy (HP:0100578) | 3.26504035 |
26 | Increased variability in muscle fiber diameter (HP:0003557) | 3.23372730 |
27 | Exercise-induced muscle cramps (HP:0003710) | 3.21402249 |
28 | Venous abnormality (HP:0002624) | 3.16614662 |
29 | Type 1 muscle fiber predominance (HP:0003803) | 3.15224355 |
30 | Ankle contracture (HP:0006466) | 3.07444841 |
31 | Atrial fibrillation (HP:0005110) | 3.07324795 |
32 | Oligomenorrhea (HP:0000876) | 3.07047063 |
33 | Venous insufficiency (HP:0005293) | 3.05984330 |
34 | Sudden death (HP:0001699) | 3.04024145 |
35 | Hyperactive renin-angiotensin system (HP:0000841) | 3.02562013 |
36 | Bone cyst (HP:0012062) | 2.95629712 |
37 | Hemorrhage of the eye (HP:0011885) | 2.89476551 |
38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.89265650 |
39 | Primary atrial arrhythmia (HP:0001692) | 2.82640871 |
40 | Cervical subluxation (HP:0003308) | 2.82170702 |
41 | Supraventricular arrhythmia (HP:0005115) | 2.79679025 |
42 | Hypoglycemic coma (HP:0001325) | 2.74817482 |
43 | Lymphangioma (HP:0100764) | 2.74488097 |
44 | Hypertriglyceridemia (HP:0002155) | 2.70293825 |
45 | Mesangial abnormality (HP:0001966) | 2.68658665 |
46 | Chondrocalcinosis (HP:0000934) | 2.68373342 |
47 | Muscle stiffness (HP:0003552) | 2.66359746 |
48 | Neonatal short-limb short stature (HP:0008921) | 2.64753799 |
49 | Supraventricular tachycardia (HP:0004755) | 2.63871569 |
50 | Prominent supraorbital ridges (HP:0000336) | 2.62909827 |
51 | Flat acetabular roof (HP:0003180) | 2.58327282 |
52 | Aneurysm (HP:0002617) | 2.57900377 |
53 | Round ear (HP:0100830) | 2.56813588 |
54 | Abnormality of Sharpey fibers (HP:0100685) | 2.55894797 |
55 | Abnormality of complement system (HP:0005339) | 2.55151963 |
56 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.50990660 |
57 | Abnormality of carpal bone ossification (HP:0006257) | 2.43743895 |
58 | Thin bony cortex (HP:0002753) | 2.43375351 |
59 | Dilatation of the ascending aorta (HP:0005111) | 2.41186679 |
60 | Absent toe (HP:0010760) | 2.41007830 |
61 | Spinal cord compression (HP:0002176) | 2.40929071 |
62 | Facial diplegia (HP:0001349) | 2.38324596 |
63 | Complement deficiency (HP:0004431) | 2.38096217 |
64 | Shallow orbits (HP:0000586) | 2.37982586 |
65 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.37875916 |
66 | Soft skin (HP:0000977) | 2.37302954 |
67 | Hyperparathyroidism (HP:0000843) | 2.37134356 |
68 | Dilated cardiomyopathy (HP:0001644) | 2.37103585 |
69 | Hypoplasia of the iris (HP:0007676) | 2.37019933 |
70 | Systemic lupus erythematosus (HP:0002725) | 2.35399493 |
71 | Hypoalphalipoproteinemia (HP:0003233) | 2.32864253 |
72 | Myotonia (HP:0002486) | 2.31646240 |
73 | Bladder diverticulum (HP:0000015) | 2.30950700 |
74 | EMG: myopathic abnormalities (HP:0003458) | 2.30286914 |
75 | Decreased circulating renin level (HP:0003351) | 2.29050187 |
76 | Alkalosis (HP:0001948) | 2.28575680 |
77 | Hematochezia (HP:0002573) | 2.28460511 |
78 | Axonal loss (HP:0003447) | 2.27480554 |
79 | Arterial tortuosity (HP:0005116) | 2.23500763 |
80 | Abnormality of the anterior chamber (HP:0000593) | 2.21914746 |
81 | Myoglobinuria (HP:0002913) | 2.20365292 |
82 | Osteolytic defects of the hand bones (HP:0009699) | 2.19815900 |
83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19815900 |
84 | Wrist flexion contracture (HP:0001239) | 2.18716990 |
85 | Abnormality of the calf musculature (HP:0001430) | 2.18030448 |
86 | Pigmentary retinal degeneration (HP:0001146) | 2.16309386 |
87 | Growth hormone excess (HP:0000845) | 2.15131943 |
88 | Metabolic alkalosis (HP:0200114) | 2.14710209 |
89 | Muscular dystrophy (HP:0003560) | 2.14223360 |
90 | Abnormal delivery (HP:0001787) | 2.14118122 |
91 | Distal lower limb muscle weakness (HP:0009053) | 2.13973506 |
92 | Elbow flexion contracture (HP:0002987) | 2.13657497 |
93 | Xanthomatosis (HP:0000991) | 2.12105453 |
94 | Abnormality of the acetabulum (HP:0003170) | 2.11716613 |
95 | Flat capital femoral epiphysis (HP:0003370) | 2.11443470 |
96 | Distal lower limb amyotrophy (HP:0008944) | 2.11250322 |
97 | Back pain (HP:0003418) | 2.10701049 |
98 | Abnormality of proline metabolism (HP:0010907) | 2.10530374 |
99 | Hydroxyprolinuria (HP:0003080) | 2.10530374 |
100 | Deep venous thrombosis (HP:0002625) | 2.10186789 |
101 | Mitral stenosis (HP:0001718) | 2.10182524 |
102 | Cardiovascular calcification (HP:0011915) | 2.09908552 |
103 | Atrophic scars (HP:0001075) | 2.08007098 |
104 | Coronal craniosynostosis (HP:0004440) | 2.07862400 |
105 | Breech presentation (HP:0001623) | 2.07527077 |
106 | Scapular winging (HP:0003691) | 2.07493598 |
107 | Coxa vara (HP:0002812) | 2.07338937 |
108 | Calf muscle hypertrophy (HP:0008981) | 2.06754904 |
109 | Abnormal hemoglobin (HP:0011902) | 2.06179325 |
110 | Wormian bones (HP:0002645) | 2.06112533 |
111 | Ovoid vertebral bodies (HP:0003300) | 2.04775089 |
112 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.04106548 |
113 | Intrahepatic cholestasis (HP:0001406) | 2.02776060 |
114 | Difficulty climbing stairs (HP:0003551) | 2.02417280 |
115 | Abnormality of renin-angiotensin system (HP:0000847) | 2.01870730 |
116 | Abnormality of dentin (HP:0010299) | 2.01713565 |
117 | Esophageal varix (HP:0002040) | 2.01241619 |
118 | Joint stiffness (HP:0001387) | 2.00839420 |
119 | Neck muscle weakness (HP:0000467) | 1.99858250 |
120 | Short nail (HP:0001799) | 1.99492597 |
121 | Hypoplastic ischia (HP:0003175) | 1.98264749 |
122 | Achilles tendon contracture (HP:0001771) | 1.97561326 |
123 | Insulin resistance (HP:0000855) | 1.97308943 |
124 | Spontaneous hematomas (HP:0007420) | 1.97242608 |
125 | Exercise-induced myalgia (HP:0003738) | 1.96641068 |
126 | Cerebral hemorrhage (HP:0001342) | 1.95353893 |
127 | Toxemia of pregnancy (HP:0100603) | 1.95169262 |
128 | Blue sclerae (HP:0000592) | 1.94910707 |
129 | Absent hand (HP:0004050) | 1.94443037 |
130 | Abnormal ossification of hand bones (HP:0005921) | 1.94342119 |
131 | Ectopia lentis (HP:0001083) | 1.94160204 |
132 | Ileus (HP:0002595) | 1.94031197 |
133 | Prolonged QT interval (HP:0001657) | 1.93795317 |
134 | Abnormality of the Achilles tendon (HP:0005109) | 1.91696320 |
135 | Follicular hyperkeratosis (HP:0007502) | 1.91361955 |
136 | Hyperlipoproteinemia (HP:0010980) | 1.90687287 |
137 | Adactyly (HP:0009776) | 1.90571734 |
138 | Fragile skin (HP:0001030) | 1.90325525 |
139 | Fat malabsorption (HP:0002630) | 1.89803516 |
140 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.89526813 |
141 | Rhabdomyolysis (HP:0003201) | 1.89435465 |
142 | Decreased subcutaneous fat (HP:0001002) | 1.89254384 |
143 | Abdominal distention (HP:0003270) | 1.86968989 |
144 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.86647022 |
145 | Abnormal cartilage morphology (HP:0002763) | 1.85251342 |
146 | Myocardial infarction (HP:0001658) | 1.85012269 |
147 | Bradycardia (HP:0001662) | 1.84383950 |
148 | Malnutrition (HP:0004395) | 1.83256288 |
149 | Palpitations (HP:0001962) | 1.83159784 |
150 | Abnormality of the ischium (HP:0003174) | 1.82346029 |
151 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.82241365 |
152 | Generalized amyotrophy (HP:0003700) | 1.81943950 |
153 | Flattened epiphyses (HP:0003071) | 1.79501263 |
154 | Premature skin wrinkling (HP:0100678) | 1.77842269 |
155 | Distal upper limb amyotrophy (HP:0007149) | 1.77542855 |
156 | Upper limb amyotrophy (HP:0009129) | 1.77542855 |
157 | Cupped ribs (HP:0000887) | 1.76621685 |
158 | Mitral regurgitation (HP:0001653) | 1.74233087 |
159 | Vascular calcification (HP:0004934) | 1.72798956 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 7.93786152 |
2 | KDR | 5.37580326 |
3 | MYLK | 4.08829250 |
4 | EPHB2 | 2.96712577 |
5 | CAMK1D | 2.59846922 |
6 | TTN | 2.52677682 |
7 | TGFBR2 | 2.34407244 |
8 | PDGFRA | 2.33099111 |
9 | TRIB3 | 2.20458085 |
10 | CAMK1G | 1.84301564 |
11 | PTK2B | 1.82824452 |
12 | GRK1 | 1.82489463 |
13 | MAP3K12 | 1.72880611 |
14 | ERN1 | 1.65886884 |
15 | IRAK3 | 1.53456525 |
16 | FRK | 1.50561167 |
17 | RIPK1 | 1.48102145 |
18 | PAK2 | 1.45776708 |
19 | PIK3CA | 1.43711952 |
20 | SIK1 | 1.41262901 |
21 | EPHA3 | 1.40530169 |
22 | DMPK | 1.34782771 |
23 | PDK2 | 1.33347264 |
24 | MAP2K3 | 1.31731117 |
25 | BCKDK | 1.30589963 |
26 | TRPM7 | 1.24082711 |
27 | PHKG2 | 1.22180162 |
28 | PHKG1 | 1.22180162 |
29 | FER | 1.21325295 |
30 | NTRK1 | 1.19208861 |
31 | MAPKAPK3 | 1.18660470 |
32 | ARAF | 1.18257173 |
33 | NUAK1 | 1.12073120 |
34 | TGFBR1 | 1.05752331 |
35 | LMTK2 | 1.05554104 |
36 | PAK3 | 1.02009123 |
37 | MET | 1.00256973 |
38 | MAP2K1 | 1.00097352 |
39 | MAPK12 | 0.98244469 |
40 | STK38 | 0.96681096 |
41 | PRKAA2 | 0.96527225 |
42 | INSRR | 0.94993360 |
43 | DAPK3 | 0.94613853 |
44 | ICK | 0.94193954 |
45 | ILK | 0.93231764 |
46 | PRPF4B | 0.89743184 |
47 | PRKD1 | 0.89446368 |
48 | NME2 | 0.88642968 |
49 | KIT | 0.88034764 |
50 | PRKG2 | 0.87561720 |
51 | GRK5 | 0.87536708 |
52 | PDGFRB | 0.87317682 |
53 | PDPK1 | 0.87297926 |
54 | ROCK1 | 0.83887175 |
55 | MOS | 0.83184581 |
56 | LIMK1 | 0.82677197 |
57 | DDR2 | 0.79392642 |
58 | EPHB1 | 0.77925651 |
59 | PDK3 | 0.77688947 |
60 | PDK4 | 0.77688947 |
61 | STK39 | 0.77440259 |
62 | LATS2 | 0.77114806 |
63 | BMX | 0.76647726 |
64 | OBSCN | 0.76537682 |
65 | PRKD3 | 0.76348646 |
66 | AKT3 | 0.75001922 |
67 | CDK9 | 0.71388301 |
68 | DAPK2 | 0.70995547 |
69 | LATS1 | 0.70387687 |
70 | PIK3CG | 0.69423268 |
71 | NEK9 | 0.68723036 |
72 | PTK6 | 0.64474498 |
73 | PAK4 | 0.63853042 |
74 | MAP3K3 | 0.60947810 |
75 | CAMK2D | 0.60852900 |
76 | INSR | 0.60550290 |
77 | BCR | 0.59461265 |
78 | MAPK11 | 0.59260481 |
79 | PIM2 | 0.58906939 |
80 | MAPK7 | 0.58854241 |
81 | CAMK2G | 0.58263739 |
82 | WNK4 | 0.58033339 |
83 | PKN2 | 0.57939289 |
84 | PTK2 | 0.57032970 |
85 | JAK1 | 0.56916208 |
86 | STK24 | 0.54914276 |
87 | CDC42BPA | 0.53847719 |
88 | ABL2 | 0.53429236 |
89 | ZAK | 0.52840762 |
90 | MAP3K2 | 0.52175894 |
91 | ACVR1B | 0.52171178 |
92 | TEC | 0.52044690 |
93 | SCYL2 | 0.51420295 |
94 | IGF1R | 0.51262443 |
95 | CDK8 | 0.50975032 |
96 | PRKCE | 0.50265323 |
97 | TESK1 | 0.50039240 |
98 | EEF2K | 0.49830848 |
99 | SMG1 | 0.49167371 |
100 | MAP2K2 | 0.48494513 |
101 | RET | 0.47709185 |
102 | MAPK4 | 0.47511910 |
103 | FGFR2 | 0.46004807 |
104 | MAP3K11 | 0.45901229 |
105 | RPS6KA2 | 0.45454969 |
106 | TESK2 | 0.44533424 |
107 | CAMK1 | 0.44281075 |
108 | FLT3 | 0.44255158 |
109 | MAP3K1 | 0.41827211 |
110 | KSR2 | 0.41176245 |
111 | MAPK15 | 0.40565407 |
112 | BRAF | 0.39192053 |
113 | ZAP70 | 0.39189947 |
114 | CAMK4 | 0.38573244 |
115 | PRKD2 | 0.37743039 |
116 | SRC | 0.37544178 |
117 | LRRK2 | 0.37259563 |
118 | NEK1 | 0.37162538 |
119 | CAMK2B | 0.36893028 |
120 | PAK1 | 0.35825742 |
121 | FGFR4 | 0.34842375 |
122 | MAP3K6 | 0.34444179 |
123 | TBK1 | 0.34185316 |
124 | MTOR | 0.33921309 |
125 | GSK3A | 0.33372501 |
126 | PRKACG | 0.32542920 |
127 | ROCK2 | 0.32512257 |
128 | MST1R | 0.32079398 |
129 | PINK1 | 0.30887215 |
130 | ERBB3 | 0.30838619 |
131 | PRKCH | 0.30281368 |
132 | CAMKK2 | 0.30065005 |
133 | MAP3K8 | 0.29453462 |
134 | EPHA2 | 0.29416963 |
135 | ADRBK1 | 0.29416144 |
136 | MAPKAPK2 | 0.29193042 |
137 | MAPKAPK5 | 0.28861369 |
138 | EGFR | 0.28494472 |
139 | JAK3 | 0.27679738 |
140 | AKT2 | 0.27220088 |
141 | CSK | 0.26906572 |
142 | MUSK | 0.26361130 |
143 | ERBB4 | 0.25760714 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.52460195 |
2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.22982108 |
3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.88317496 |
4 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.78476160 |
5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.73038640 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.71699717 |
7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.64599586 |
8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.58160136 |
9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.55761384 |
10 | Focal adhesion_Homo sapiens_hsa04510 | 2.54686744 |
11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.47366590 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.15147213 |
13 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.09070701 |
14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.08403049 |
15 | Sulfur relay system_Homo sapiens_hsa04122 | 2.07323103 |
16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.05484857 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.03800616 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.03063137 |
19 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.90305100 |
20 | Retinol metabolism_Homo sapiens_hsa00830 | 1.89908143 |
21 | Malaria_Homo sapiens_hsa05144 | 1.66587137 |
22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64982459 |
23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63365884 |
24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.60736693 |
25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.57912869 |
26 | Adherens junction_Homo sapiens_hsa04520 | 1.57352614 |
27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.54656372 |
28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53539578 |
29 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.53508284 |
30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.49966117 |
31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47256317 |
32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.41068852 |
33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39079384 |
34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.37981946 |
35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.36363434 |
36 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.32361329 |
37 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.31901597 |
38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.28326960 |
39 | Galactose metabolism_Homo sapiens_hsa00052 | 1.27264186 |
40 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.26085298 |
41 | Mineral absorption_Homo sapiens_hsa04978 | 1.25551823 |
42 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.23459414 |
43 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.21779302 |
44 | Amoebiasis_Homo sapiens_hsa05146 | 1.18551310 |
45 | Tight junction_Homo sapiens_hsa04530 | 1.17233625 |
46 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.14927534 |
47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14169038 |
48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13941602 |
49 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.11683157 |
50 | Renin secretion_Homo sapiens_hsa04924 | 1.08854151 |
51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06940585 |
52 | Parkinsons disease_Homo sapiens_hsa05012 | 1.05612942 |
53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.05390208 |
54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04055640 |
55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.02297662 |
56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02079066 |
57 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.01413933 |
58 | Insulin resistance_Homo sapiens_hsa04931 | 0.99458869 |
59 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98904352 |
60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.97964750 |
61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.97447283 |
62 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.97030188 |
63 | Platelet activation_Homo sapiens_hsa04611 | 0.96222206 |
64 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.94027571 |
65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93119518 |
66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92462286 |
67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90878376 |
68 | Bile secretion_Homo sapiens_hsa04976 | 0.90034314 |
69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89313880 |
70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.87283599 |
71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87010092 |
72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86686856 |
73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84176009 |
74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81399760 |
75 | Pathways in cancer_Homo sapiens_hsa05200 | 0.81352270 |
76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80869523 |
77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79184514 |
78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79141797 |
79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77902965 |
80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.77661389 |
81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76548847 |
82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76497903 |
83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76403689 |
84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.74722248 |
85 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74505009 |
86 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74394560 |
87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74270823 |
88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70348658 |
89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69099406 |
90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68089866 |
91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67957779 |
92 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64863265 |
93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62960675 |
94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.62790034 |
95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62424151 |
96 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62320383 |
97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60357829 |
98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59842878 |
99 | Gap junction_Homo sapiens_hsa04540 | 0.58973218 |
100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57833959 |
101 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.57541600 |
102 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55643061 |
103 | Melanoma_Homo sapiens_hsa05218 | 0.55213292 |
104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55027127 |
105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54979857 |
106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54794314 |
107 | Peroxisome_Homo sapiens_hsa04146 | 0.54391056 |
108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54254973 |
109 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52102253 |
110 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.51798468 |
111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49884567 |
112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48896615 |
113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48555467 |
114 | ABC transporters_Homo sapiens_hsa02010 | 0.48435757 |
115 | Axon guidance_Homo sapiens_hsa04360 | 0.47511866 |
116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46450425 |
117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46398845 |
118 | Melanogenesis_Homo sapiens_hsa04916 | 0.46361434 |
119 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46256699 |
120 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46069110 |
121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45748773 |
122 | Endocytosis_Homo sapiens_hsa04144 | 0.45216397 |
123 | Prion diseases_Homo sapiens_hsa05020 | 0.44967043 |
124 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43943651 |
125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43757093 |
126 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43173945 |
127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42704388 |
128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42482827 |
129 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42446591 |
130 | Salivary secretion_Homo sapiens_hsa04970 | 0.41155668 |
131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40555731 |
132 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40392179 |
133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39113713 |
134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39058777 |
135 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38322047 |
136 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33397920 |
137 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32669294 |
138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.31557189 |
139 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28975988 |
140 | Lysine degradation_Homo sapiens_hsa00310 | 0.28409587 |
141 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27867163 |
142 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.25163227 |
143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24728727 |